Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 19/20 | 0.72 |
| ▸ | PARP2 | Q9UGN5 | 8/20 | 0.72 |
| ▸ | PARP6 | Q2NL67 | 3/20 | 0.45 |
| ▸ | PARP3 | Q9Y6F1 | 3/20 | 0.45 |
| ▸ | TNKS | O95271 | 1/20 | 0.45 |
| ▸ | TIPARP | Q7Z3E1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30414526 | 0.88 | PARP1 (0.58) | PARP1PARP2PARP6PARP3TNKS | |
| SCHEMBL25192086 | 0.84 | PARP1 (1.00) | PARP1PARP2PARP6PARP3TNKS | |
| SCHEMBL30893600 | 0.80 | PARP1 (0.49) | PARP1PARP2PARP6PARP3TNKS | |
| SCHEMBL31424725 | 0.79 | PARP1 (0.55) | PARP1PARP2PARP6PARP3TNKS | |
| SCHEMBL30414803 | 0.79 | PARP1 (0.49) | PARP1PARP2 | |
| SCHEMBL30893591 | 0.77 | PARP1 (0.52) | PARP1PARP2PARP6PARP3TNKS | |
| SCHEMBL20962645 | 0.75 | PARP1 (0.51) | PARP1PARP2 | |
| SCHEMBL30414229 | 0.75 | PARP1 (0.48) | PARP1PARP2PARP6PARP3TNKS | |
| SCHEMBL30385483 | 0.74 | PARP1 (0.50) | PARP1PARP2PARP6PARP3TNKS | |
| SCHEMBL30385332 | 0.74 | PARP1 (0.52) | PARP1PARP2PARP6PARP3TNKS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118055933-A | Selective PARP1 inhibitors and uses thereof | 成都百裕制药股份有限公司 | 2024-05-17 | — | — | CN | disclosed |
| WO-2023088408-A1 | SELECTIVE PARP1 INHIBITOR AND APPLICATION THEREOF | 成都百裕制药股份有限公司 | 2023-05-25 | — | — | WO | disclosed |